miR-323-3p targets one of the PDLIM family genes, out of which we have observed that PDLIM7 (Enigma) is upregulated in the same thyroid cancer tissues but not in benign tumors via the activation of MAPK and c-MYC (unpublished data). Here, MYC is linked to benign neoplasm.